Streetwise Articles
Drug Innovator Launches Pivotal Cancer Trial Breakthrough
Source: Sean Lee (1/3/25)
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) has the potential to generate hundreds of millions of dollars over the next decade with its drug candidates, an H.C. Wainwright & Co. analyst wrote in a January 2 research note.
More >
Stocks Are Bouncing
(1/3/25)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market and one gold stock he thinks is a Buy.
More >
High-Grade Gold Discoveries in Nevada Reveal Significant Potential For 2025
Source: Streetwise Reports (1/3/25)
Nevada King Gold Corp. (NKGFF:OTCMKTS; NKG:TSX) continues to advance its Atlanta Gold Project with high-grade discoveries and resource expansion potential. Learn whats driving their success and whats next for this Nevada asset.
Should You Buy on These Silver Stock Dips?
Source: Shad Marquitz (1/2/25)
Shad Marquitz of Excelsior Prosperity explains why he plans to buy silver stock juniors on dips.
More >
Liberia's Dugbe Gold Project: A Strategic Asset Driving Growth and Sustainability
Source: Streetwise Reports (1/2/25)
Pasofino Gold Ltd. (VEIN:TSX.V) is a Canadian-based mineral exploration company listed on the TSX Venture Exchange and Frankfurt Stock Exchange. Read more to see why one technical analyst thinks the stock is an Immediate Strong Buy.
More >
Why 5 Experts Like Argentinean-Focused Silver and Gold Explorer
Source: Streetwise Reports (1/2/25)
Their numerous reasons include the project's location, size, projected economics, resource growth potential and likelihood to be taken out. Read on for the specifics.
More >
Miami Biopharma Sells Part of Business and Begins New Clinical Trial
Source: Dr. Yi Chen (1/2/25)
Miami biopharmaceutical company Veru Inc. (VERU:NASDAQ) recently sold its FC2 Female Condom business for US$18 million, and has begun enrolling patients for its The Phase 2b QUALITY trial of enobosarm in combination with Wegovy (semaglutide) for sarcopenic obesity. Read on to see why one analyst gives this company a Buy rating.
More >
Massive High-Grade Discovery in Newfoundland Exceeds Expectations
Source: Streetwise Reports (1/2/25)
Canterra Minerals Corp. (CTM:TSX.V; CTMCF:OTC) uncovers high-grade silver potential at its Nevada project. Could this discovery redefine the region's mining landscape in 2025?
More >
Gold Developer Unlocks Major Funding for Historic Canadian Mine
Source: Streetwise Reports (1/2/25)
West Red Lake Gold Mines Inc. (WRLG:TSX.V; WRLGF:OTCQB) announces the completion of a US$35 million credit facility with Nebari Natural Resources Credit Fund II LP. Find out why one analyst writes that the company's exploration plans have "good potential for resource expansion."
More >
Opening Volatility
Source: Michael Ballanger (1/2/25)
Michael Ballanger of GGM Advisory Inc. takes a look at VIS:US this morning.
More >
Gold Explorer Ready To Break Out of a Large Base
Source: Clive Maund (12/31/24)
Technical Analyst Clive Maund explains why he thinks Pasofino Gold Ltd. (VEIN:TSX.V) is an Immediate Strong Buy.
More >
Advanced Counter-Drone Solutions Drive Growth in Emerging Security Industry
Source: Streetwise Reports (12/31/24)
DroneShield Ltd. (DRO:ASX; DRSHF:OTC) has advanced its portfolio of detection and neutralization solutions to become a prominent developer of counter-drone technologies in the counter-unmanned aerial systems industry. Read more to find out how this innovative approach is shaping the future of counter-drone technology and driving growth in the C-UAS sector.
More >
Strategic Executive Hires Propel Lithium Company Forward
Source: Streetwise Reports (12/31/24)
Atlas Lithium Corp. (ATLX:NASDAQ), situated in Brazil's Lithium Valley, has made two strategic executive hires to strengthen its production capabilities and global market presence. Read more about these new hires and their roles in advancing production and expanding global reach.
More >
Analyst Initiates Coverage of Co. With 'Once-in-a-Generation' Drug
Source: Ed Arce (12/31/24)
NewAmsterdam Pharma Company N.V.'s (NAMS:NASDAQ) drug obicetrapib is a "once-in-a-generation" drug for cardiovascular disease, an analyst wrote in a research note while initiating coverage on the company. See what rating the stock got and its price per share target.
More >
Analyst Sees Major Growth for Biopharma With Weight-Loss Drug
Source: Ed Arce (12/31/24)
Recent successes of weight-loss drugs like Ozempic and Wegovy have led H.C. Wainwright & Co. Analyst Ed Arce to be "intrigued" by MetaVia Inc.'s (MTVA:NASDAQ) new drug candidate.
More >
One Contrarian Buy in the Lithium Space
Source: Michael Ballanger (12/31/24)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market and one lithium stock he considers a Buy despite market sentiment.
More >
New Metallurgical Findings Would Boost Project NAV
Source: Varun Arora (12/30/24)
Improved metals recoveries make the economics of this three-deposit, polymetallic project in Spain compelling, noted a Clarus Securities report.
More >
Stocks Look To Add to the Friday Losses
Source: Michael Ballanger (12/30/24)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market as we head into the new year.
More >
Parkinson's Treatment Advancements: Clinical Trials Begin for Potential New Therapy
Source: Streetwise Reports (12/30/24)
Gain Therapeutics Inc. (GANX:NASDAQ) has announced the initiation of its Phase 1b clinical trial for GT-02287, a lead candidate targeting Parkinsons disease (PD), following regulatory approval in Australia. Read more about the trial aiming to redefine Parkinsons treatment and its potential global impact.
More >
Tech Co. Goes Public, Looks to Debut 'Digital Gold' Offering
Source: Streetwise Reports (12/27/24)
Matador Technologies Inc. (MATA:TSX.V), which is focused on digitizing real-world assets (RWAs) on the blockchain, beginning with digital gold, is now listed on the TSX Venture Exchange. Read why one expert thinks the marriage of technology and precious metals will attract younger investors.
More >
2025 Crypto Outlook: Eight Themes To Watch
Source: Alex Tapscott (12/27/24)
Alex Tapscott, managing director of the Digital Asset Group, a division of Ninepoint Partners LP, shares his 2025 outlook for crypto and AI.
More >
Gold Co. Close To Breaking Out of a Giant Base Pattern
Source: Clive Maund (12/27/24)
Technical Analyst Clive Maund explains why he thinks Soma Gold Corp. (TSXV:SOMA; OTC:SMAGF; WKN:A2P4DU) is an Immediate Strong Buy.
More >
High-Grade Silver-Gold Projects Advance with Milestone Resource Estimates in Early 2025
Source: Streetwise Reports (12/27/24)
Summa Silver Corp. (SSVR:TSX.V; SSVRF:OTC) is advancing its Hughes and Mogollon silver-gold projects in the southwestern United States, with inaugural mineral resource estimates (MREs) scheduled for release in early 2025. Explore how extensive drilling and high-grade discoveries support the companys belief in the growth potential of these U.S. silver-gold projects in the new year.
More >
Barrick Takes Mali to Arbitration, Situation 'Untenable'
Source: Adrian Day (12/27/24)
Global Analyst Adrian Day discusses developments at several companies on his list, some positive, some less so.
More >
Gold Co. Embarks on Phase III Drilling Program
Source: Mike Niehuser (12/27/24)
Nevada King Gold Corp. (NKGFF:OTCMKTS; NKG:TSX) recently started its Phase III drilling program at its Atlanta Gold Project, according to a Roth MKM research note.
More >